emergency care News
-
Early detection of concussion can mitigate premature returning to play decisions
An interview with the lead author from The American Journal of Sports Medicine, Effects of the New York State Concussion Management and Awareness Act (“Lystedt Law”) on Concussion-Related Emergency Health Care Utilization Among Adolescents, 2005-2015 (here). More on Zack Lystadt's concussion survivor's journey (here). ...
-
TargetSolutions’ EMS Continuing Education Course Examines Emergency Care for Allergies and Anaphylaxis
TargetSolutions’ EMS Allergies and Anaphylaxis Basic training course covers the topics of allergy-related incidents and the appropriate care needed in such situations. Allergic reactions can develop as simple irritations, but quickly mobilize into life-threatening emergencies. EMS responders are tasked with determining the severity of the condition as emergency medical care and rapid ...
-
Ensuring Patients` Safety through CO₂ Monitoring
Leister Corporate, Axetris, Infrared Sources, Medical Axetris EMIRS50 - made for compact NDIR capnography sensors. Its compact size, high emission at 4.26μm and an integrated reflector that improves efficiency makes Axetris' infrared source EMIRS50 make the first choice when it comes to integrating it in capnography analyzers. Capnography is a non-invasive method that measures ...
By Axetris AG
-
Thomas Kolaras Joins SERB and BTG Specialty Pharmaceuticals as US Chief Commercial Officer
SERB and BTG Specialty Pharmaceuticals are pleased to announce that Thomas Kolaras has been named the group’s new Chief Commercial Officer for its US business. Thomas is an accomplished commercial leader with more than 25 years of US and global experience across large and mid-sized biopharmaceutical companies. His career includes a wide range of roles in marketing, sales, operations, ...
-
TX Series added to CoTCCC list of recommended limb tourniquets
RevMedx, Inc., a leader in groundbreaking solutions for the control of severe bleeding, today announced that the CoTCCC has added the TX Series ratcheting tourniquets to its list of recommended Limb Tourniquets. The TX series joins the XSTAT® injectable hemostatic on the TCCC list of recommended hemorrhage control devices for casualty care. Andrew Barofsky, President and CEO of RevMedx, ...
By RevMedx
-
SERB acquires the rights to Xermelo outside US and Japan for Carcinoid Syndrome Diarrhoea
SERB is pleased to announce it has acquired the rights from Ipsen to commercialize Xermelo® (telotristat ethyl) in Europe and other countries outside the US and Japan. Financial terms of the transaction were not disclosed. Xermelo is indicated for the treatment of carcinoid syndrome diarrhoea (CSD) in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by ...
-
Ben Watt Joins SERB and BTG as Group CFO
SERB and BTG Specialty Pharmaceuticals are pleased to announce that Ben Watt has been named the group’s new Chief Financial Officer. Ben is an experienced CFO with a track record of building global finance teams and integrating business acquisitions. Ben most recently served as CFO of Crouzet, an independent manufacturer of electronic components used in heavily regulated industries. He ...
-
RevMedx receives CE Mark for XSTAT® injectable hemostatic devices
Revolutionary bleeding control technology will now be available in Europe and other International markets. RevMedx, Inc., a leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XSTAT 30 and XSTAT 12 hemostatic devices in Europe. Unlike traditional wound treatments that may take several ...
By RevMedx
-
RevMedx announces adoption of XSTAT gunshot wound treatment by emergency responders in Highland Park, Texas
RevMedx, Inc. announced today that the Highland Park Department of Public Safety (Highland Park, TX) is fielding XSTAT as a new treatment option in their medical and trauma kits. Located three miles north of Dallas, Highland Park Department of Public Safety works closely with other Dallas Metro services including Dallas Fire and Rescue and University Park Fire Department on Automatic Assistance ...
By RevMedx
-
HORIBA Medical welcomes the latest member of the new Yumizen H500 family
As a result of a growing research and development program, HORIBA Medical has recently developed two new products that aim to better meet the needs of today's clinical laboratories : The Yumizen H500 OT ‘Open Tube’ with flexible sampling to accommodate all sample types, particularly for rapid screening in critical care, emergency care and pediatric clinics. The new released ...
-
RevMedx receives CE Mark for XGAUZE® self-expanding gauze.
Manufacturer of the revolutionary XSTAT technology will now have a second sterile wound dressing available in Europe and other International markets. RevMedx, Inc., a global leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XGAUZE wound dressing in Europe. XGAUZE, a Class I sterile ...
By RevMedx
-
ANX ROBOTICA RECEIVES FDA DE-NOVO CLASSIFICATION FOR FIRST-OF-ITS-KIND NAVICAM™ REMOTE-CONTROLLED CAPSULE ENDOSCOPY SYSTEM FOR THE STOMACH
Plano, Texas (June 4, 2020) AnX Robotica Corporation today announced it has been granted by the Food and Drug Administration (FDA) De-Novo classification for its NaviCamTM Magnetically Controlled Capsule Endoscopy (MCCE) System. The first-of-its-kind system allows complete, real-time visualization of the stomach utilizing a pill-sized capsule containing a camera and is remote-controlled by the ...
By AnX Robotica
-
Christie Medical Holdings, Inc. Partners with DO-PA A.S. for Turkey Distribution
As the leader in vein visualization technology throughout the world, Christie’s high-quality, made-in-the USA, VeinViewer®Vision2 and VeinViewer® Flex, continue to provide customers with improved clinical outcomes such as increasing 1st stick success, decreasing medically not required PICC lines and enhancing patient satisfaction. We are committed to the continued growth of ...
-
SERB receives EU approval for Voraxaze (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity
SERB and BTG Specialty Pharmaceuticals announced that the European Commission has granted marketing authorisation for Voraxaze (glucarpidase) to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk of methotrexate toxicity. Voraxaze is now authorized for marketing in all members states of the European Union ...
-
ID Genomics’ technology covered by GeekWire
The idea is simple: when a patient has a bacterial infection, doctors should find out what kind of bacteria it is so they can give the most effective treatment. But growing bacteria in a lab to identify it takes hours to days. That means doctors have to make their best guess, and because there are dozens of possible strains, they guess wrong up to a third of the time. Seattle biotech startup ID ...
-
First Evidence of High-Dose Methotrexate Related Toxicity in Spain Presented at Virtual ISPOR Europe 2021
The first evidence of high dose methotrexate related toxicity (HDMTX) in Spain was presented today at Virtual ISPOR Europe 2021, a global conference on healthcare economics and outcomes. Xavier Badia, MD, MPH, PhD of Omakase Consulting S.L. presented the poster titled “Epidemiology and Clinical Management of Patients with Methotrexate Toxicity in Spain Using the Delphi Technique,” ...
-
SERB receives positive CHMP opinion for Voraxaze (glucarpidase) as Rescue Therapy for High Dose Methotrexate Toxicity
SERB and BTG Specialty Pharmaceuticals today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending a marketing authorisation for Voraxaze (glucarpidase) to reduce toxic plasma methotrexate concentration in adults and children (aged 28 days and older) with delayed methotrexate elimination or at risk ...
-
Asensus Surgical, Inc. Announces Sapporo Medical University Hospital in Japan to Initiate Senhance Robotic Surgery Program
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced Sapporo Medical University Hospital, located in Hokkaido, Japan, has entered into an agreement to lease and utilize a Senhance® Surgical System. “The Department of Surgery, ...
-
Queen’s University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities
Hyperfine, Inc. (Nasdaq:HYPR), creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, is proud to announce that Queen’s University and Kingston Health Sciences Centre are deploying a Swoop system as part of their health services benefitting six communities located in the James Bay and Hudson Bay Area. Until now, patients needing routine or ...
By Hyperfine
-
Oncomfort and Vygon sign international partnership for commercialization of Sedakit™, the Digital Sedation™ Virtual Reality solution
Oncomfort, the Belgian inventor of Digital SedationTM - a new method for relieving patients’ pain and anxiety without medication –, and Vygon, global group specializing in single-use medical devices, today announce their commercial partnership in six European countries. The strong synergy between Vygon's specialization and Oncomfort's fields of application will enable greater ...
By Oncomfort
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you